Introduction
& Objectives

 

Interactions/Warnings

TIKOSYN is contraindicated in patients with congenital or acquired long QT syndromes. TIKOSYN should not be used in patients with a baseline QT interval or QTc >440 msec (500 msec in patients with ventricular abnormalities). TIKOSYN is also contraindicated in patients with severe renal impairment (calculated creatinine clearance <20 mL/min).

Mechanism
of Action

Pharmacokinetics

Contraindications/
Drug Interactions
Dosing
Tolerability
Patient Education
View TIKOSYN PI